Polymorphisms of the ß2 adrenoreceptor gene in chronic obstructive pulmonary disease

Therapeutic Advances in Respiratory Disease

Volumn 3, Issue 1, 2009, Pages 3-10

  Vacca, Gabriela ^a   Schwabe, Kerstin ^a   Dück, Ramona ^a   Hlawa, Hans Peter ^b   Westphal, Arite ^b   Pabst, Stefan ^c   Grohé, Christian ^d   Gillissen, Adrian ^a  

^a Robert Koch Klinik   (Germany)

^b Department of Pneumology ^*  (Germany)

^c UNIVERSITY OF BONN   (Germany)

^d Department of Pulmonary Medicine   (Germany)

Author keywords

beta 2 receptor gene; COPD; polymorphism

Indexed keywords

ANTIBIOTIC AGENT; ARGININE; BETA 2 ADRENERGIC RECEPTOR; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID; DNA; FENOTEROL; GLUTAMIC ACID; GLUTAMINE; GLYCINE; IPRATROPIUM BROMIDE; LONG ACTING DRUG; METHYLXANTHINE; PREDNISOLONE; SHORT ACTING DRUG; TIOTROPIUM BROMIDE;

AGED; ARTICLE; BLOOD ANALYSIS; CHRONIC OBSTRUCTIVE LUNG DISEASE; CIGARETTE SMOKING; CODON; CONTROLLED STUDY; DISEASE EXACERBATION; DISEASE SEVERITY; DNA ISOLATION; DNA POLYMORPHISM; DRUG DOSE REDUCTION; FEMALE; FORCED EXPIRATORY FLOW; FORCED EXPIRATORY VOLUME; GENE FREQUENCY; GENOTYPE; HAPLOTYPE; HETEROZYGOSITY; HOMOZYGOSITY; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; ALLELE; CLINICAL TRIAL; COMPARATIVE STUDY; GENETIC POLYMORPHISM; GENETIC PREDISPOSITION; GENETICS; HOSPITALIZATION; METABOLISM; MIDDLE AGED; MULTICENTER STUDY; PATHOPHYSIOLOGY; PHYSIOLOGY; PROGNOSIS;

AGED; ALLELES; DNA; FEMALE; FORCED EXPIRATORY VOLUME; GENETIC PREDISPOSITION TO DISEASE; HUMANS; MALE; MIDDLE AGED; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; PROGNOSIS; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RECEPTORS, ADRENERGIC, BETA-2; SEVERITY OF ILLNESS INDEX;

EID: 63049137608     PISSN: 17534658     EISSN: None     Source Type: Journal    
DOI: 10.1177/1753465809102553     Document Type: Article

References (51)

1. Bleeker, E.R., Yancey, S.W., Baitinger, L., Edwards, L.D., Klotsman, M., Anderson, W.H. et al. (2006) Salmeterol response is not affected by beta2-adrenergic receptor geneotype in subjects with persistent asthma, J Allergy Clin Immunol 118: 809-816.
2. Choudhry, S., Ung, N., Avila, P.C., Ziv, E., Nazario, S., Casal, J. et al. (2005) Pharmacogenetic differences in response to albuterol between Puerto Ricans and Mexicans with asthma, Am J Respir Crit Care Med 171: 563-570.
3. Davis, R.M. and Novotny, T.E. (1989) The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary diasease, Am Rev Respir Dis 140: 82-84.
4. Dewar, J.C., Wheeler, A.P., Venn, A.J., Morrison, J.F., Britton, J. and Hall, I.P. (1998) ß2-adrenoceptor polymorphisms are in linkage disequilibrium, but are not associated with asthma in an adult population, Allergy 28: 442-448.
5. Dewar, J.C., Wilkinson, J., Wheatley, A., Thomas, N.S., Doull, J., Morton, N. et al. (1997) The glutamine 27 beta2-adrenoceptor polymorphism is associated with elevated IgE levels in asthmatic families, J Allergy Clin Immunol 100: 261-265.
6. Giubergia, V., Gravina, L.P., Castanos, C., Chertkoff, L. and Grenoville, M. (2008) Influence of beta2-adrenoceptor polymorphisms on the response to chronic use of albuterol in asthmatic children, Pediatr Pulmonol 43: 421-425.
7. GOLD Executive Committee (2007) Global initiative for chronic obstructive lung disease. Available at: www.goldcopd.com
8. Green, S.A., Cole, G., Jacinto, M., Innis, M. and Liggett, S.B. (1993) A polymorphism of the human ß2-adrenergic receptor within the fourth transmembrane domain alters ligand binding and functional properties of the receptor, J Biol Chem 268: 23116-23121.
9. Green, S.A., Turki, J., Bejarno, P., Hall, I.P. and Liggett, S.B. (1995) Influence of ß2-adrenergic receptor genotypes on signal transduction in human airway smooth muscle cells, Am J Respir Cell Mol Biol 13: 25-33.
10. Green, S.A., Turki, J., Innis, M. and Liggett, S.B. (1994) Amino-terminal polymorphisms of the human ß2-receptor impart distinct agonist-promoted regulatory properties, Biochem 33: 9414-9419.
11. Hall, I.P., Wheatley, A., Wilding, P. and Liggett, S.B. (1995) Association of Glu 27 ß2-adrenoceptor polymorphism with lower airway reactivity in asthmatic subjects, Lancet 345: 1213-1214.
12. Hallberg, J., Dominicus, A., Eriksson, U.K., Gerhardsson de Verdier, M., Pedersen, N.L., Dahlbaöck, M. et al. (2008) Interaction between smoking and genetic factors in the development of chronic bronchitis, Am J Respir Crit Care Med 177: 486-490.
13. Hegab, A.E., Sakamoto, T., Saitoh, W., Massoud, H.H., Massoid, N.M., Hassanein, K.M. et al. (2004) Polymorphisms of IL4, IL13, and ADRB2 genes in COPD, Chest 126: 1832-1839.
14. Hizawa, N., Makita, H., Nasuhara, Y., Betsuyaku, T., Itoh, Y., Nagai, K. et al. (2007) Beta2-adrenergic receptor genetic polymorphisms and short-term bronchodilator responses in patients with COPD, Chest 132: 1485-1492.
15. Ho, L.-I., Harn, H.-J., Chen, C.-H. and Tsai, N.-M. (2001) Polymorphism of the ß2-adrenoceptor in COPD in Chinese subjects, Chest 120: 1493-1499.
16. Israel, E., Chinchilli, V.M., Ford, J.G., Boushey, H.A., Cherniack, R., Craig, T.J. et al. (2004) Use of regularly scheduled albuterol treatment in asthma: genotype-stratified, randomized, placebo-controlled cross-over trial, Lancet 364: 1505-1512.
17. Israel, E., Drazen, J.M., Liggett, S.B., Boushey, H.A., Cherniack, R.M., Chinchilli, V.M. et al. (2000) The effect of polymorphisms of the beta(2)-adrenergic receptor on the response to regular use of albuterol in asthma, Am J Respir Crit Care Med 162: 75-80.
18. Joos, L., Paré, P.D. and Sandford, A.J. (2002) Genetic risk factors for chronic obstructive pulmonary disease, Swiss Med Wkly 132: 27-37.
19. Joos, L., Weir, T.D., Connett, J.E., Anthonisen, N.R., Woods, R., Paré, P.D. et al. (2003) Polymorphisms in the ß2-adrenergic receptor and bronchodilator response, bronchial hyperresponsiveness, and rate of decline in lung function in smokers, Thorax 58: 703-707.
20. Kim, S.H., Oh, S.Y., Oh, H.B., Kim, Y.K., Cho, S.H., Kim, Y.Y. et al. (2006) Association of beta2-adrenoreceptor polymorphisms with nocturnal cough among atopic subjects but not with atopy and nonspecific bronchial hyperresponsiveness, J Allergy Clin Immunol 109: 630-635.
21. Kotani, Y., Nishimura, Y., Maeda, H. and Yokoyama, M. (1999) Beta2-adrenergic receptor polymorphisms affect airway responsiveness to salbutamol in asthmatics, J Asthma 36: 583-590.
22. Lee, D.K., Bates, C.E. and Lipworth, B.J. (2004) Acute systemic effects of inhaled-salbutamol in asthmatic patients subjects expressiong common homozygous beta2-adrenoceptor haplotypes at positions 16 and 27, Br J Clin Pharmacol 57: 100-104.
23. Liggett, S.B. (2000) ß2-adrenergic receptor pharmacogenetics, Am J Respir Crit Care Med 161: S161-S201.
24. Lima, J.J., Thomason, D.B., Mohamed, M.H., Eberle, L.V., Self, T.H. and Johnson, J.A. (1999) Impact of genetic polymorphisms of the beta2-adrenergic receptor on albuterol bronchodilator pharmacoedynamics, Clin Pharmacol Ther 65: 519-525.
25. Lipworth, B.J., Dempsey, O.J. and Aziz, I. (2000a) Functional antagonism with formoterol and salmeterol in asthmatic patients expressing the hmozygous glycine-16 beta(2)-adrenoceptor polymorphism, Chest 118: 321-328.
26. Lipworth, B.J., Dempsey, O.J., Aziz, I. and Wilson, A.M. (2000b) Effects of adding a leukotriene antagonist or a long-acting beta(2)-agonist in asthmatic patients with the glycine-16 beta(2)-adrenoceptor genotype, Am J Med 109: 114-121.
27. Lipworth, B.J., Hall, I.P., Aziz, I., Tan, K.S. and Wheatley, A. (1999) Beta2-adrenoceptor polymorphism and bronchoprotective sensitivity with regular short- and long-acting beta2-agonist therapy, Clin Sci (London) 96: 253-259.
28. Martinez, F.D., Graves, P.E., Baldini, M., Solomon, S. and Erickson, R. (1997) Association between genetic polymorphisms of the beta 2-adrenoceptor and response to albuterol in children with and without a history of wheezing, J Clin Invest 100: 3184-3188.
29. Matheson, M.C., Dellis, J.A., Raven, J., Johns, D.P., Walters, E.H. and Abramson, M.J. (2006) Beta2-adrenergic receptor polymorphisms are associatedwith asthma and COPD in adults, J Hum Genet 51: 943-951.
30. Moore, P.E., Laporte, J.D., Abraham, J.H., Schwartzman, I.N., Yandava, C.N., Silverman, E. et al. (2000) Polymorphism of the ß2-adrenergic receptor gene and desensitization in human airway smooth muscle, Am J Respir Crit Care Med 162: 2117-2124.
31. Nowak, D., Berger, K., Lippert, B., Kilgert, K., Caeser, M. and Sandtmann, R. (2005) Epidemiology and health economics of COPD across Europe, Treat Trespir Med 4: 381-395.
32. Palmer, C.N., Lipworth, B.J., Lee, S., Ismail, T., Macgregor, D.F. and Mukhopadhyay, S. (2006) Arginine-16 beta 2 adrenoceptor genotype predispose to exacerbations in young asthmatics taking regular salmeterol. Thorax 61: 940-944.
33. Ramsay, S.E., Hayden, C.M., Tiller, K.J., Burton, P.R., Goldblatt, J. and Lesouef, P.N. (1999) Polymorphisms in the beta2-adrenoreceptor gene are associated with decreased airway responsiveness, Clin Exp Allergy 29: 1195-1203.
34. Reihsaus, E., Innis, M., MacIntyre, N. and Liggett, S.B. (1993) Mutations in the gene encoding for the beta 2-adrenergic receptor in normal and asthmatic subjects, Am J Respir Cell Mol Biol 8: 334-339.
35. Sampsonas, F., Karkoulias, K., Kaparianos, A. and Spiropoulos, K. (2006) Genetics of chronic obstructive pulmonary disease, beyond alpha1-antitrypsin deficiency, Curr Med Chem 13: 2857-2873.
36. Silverman, E.K., Chapman, H.A., Drazen, J.M., Weiss, S.T., Rosner, B. and Campbell, E.J. (1998) Genetic epidemiology of severe, early-onset chronic obstructive pulmonary disease. Risk to relatives for airflow obstruction and chronic bronchitis, Am J Respir Crit Care Med 157: 1770-1778.
37. Silverman, E.K., Mosley, J.D., Palmer, L.J., Barth, M., Senter, J.M., Brown, A. et al. (2002) Genome-wide linkage analysis of severe, early-onset chronic obstructive pulmonary disease: airflow obstruction and chronic bronchitis phenotypes, Hum Mol Genet 11: 623-632.
38. Summerhill, E., Leavitt, S.A., Gidley, H., Parry, R., Solway, J. and Ober, C. (2000) ß2-Adrenergic receptor Arg 16/Arg 16 genotypes is associated with reduced lung function but not with asthma in the Hutteries, Am J Respir Crit Care Med 162: 599-602.
39. Tan, S., Hall, I.P., Dewar, J.C., Dow, E. and Lipworth, B.J. (1997) Association between beta2-adrenoceptor polymorphism and susceptibility to bronchodilator desensitisation in moderately severe stable asthmatics, Lancet 350: 995-999.
40. Taylor, D.R., Epton, M.J., Kennedy, M.A., Smith, D.A., Iles, S., Miller, A.L. et al. (2005) Bronchodilator response in relation to beta2-adrenoceptor haplotype in patients with asthma, Am J Respir Crit Care Med 172: 700-703.
41. Taylor, D.R., Hancox, R.J., McRae, W., Cowan, J.O., Flannery, E.M., McLachlan, C.R. et al. (2000) The influence of polymorphism at position 16 of the beta2-adrenoceptor on the development of tolerance to beta-agonist, J Asthma 37: 691-700.
42. Taylor, D.R. and Kennedy, M.A. (2002) Beta-adrenergic receptor polymorphisms and drug response in asthma, Pharmacogenomics 3: 173-184.
43. Taylor, M.R.G. (2007) Pharmacogenetics of the human beta-adrenergic receptors, Pharmacogenomics J 7: 29-37.
44. Turki, J., Pak, J., Green, S.A., Martin, R.J. and Liggett, S.B. (1995) Genetic polymorphisms of the beta 2-adrenergic receptor in nocturnal and nonocturnal asthma: evidence that Gly16 correlates with the nocturnal phenotype, J Clin Invest 95: 1635-1641.
45. Ulbrecht, M., Hergeth, M.T., Wist, M., Heinrich, J., Bickeboöller, H., Wichmann, H.-E. et al. (2000) Association of ß2-adrenoreceptor variants with bronchial hyperresponsiveness, Am J Respir Crit Care Med 161: 469-474.
46. Umeda, N., Yoashikawa, T., Kanazawa, H., Hirata, K. and Fujimoto, S. (2008) Association of beta2-adrenoreceptor genotypes with bronchodilatory effect of tiotropium in COPD, Respirology 13: 346-352.
47. Wechsler, M.E., Lehman, E., Lazarus, S.C., Lemanske, R.F., Boushey, H.A., Deykin, A. et al. (2006) ß-adrenergic receptor polymorphisms and response to salmeterol, Am J Respir Crit Care Med 173: 519-526.
48. Weir, T.D., Mallek, N., Sandford, A.J., Bai, T.R., Awadh, N., Fitzgerald, J.M. et al. (1998) beta2-adrenergic receptor haplotypes in mild, moderate and fatal/near fatal asthma, Am J Respir Crit Care Med 158: 787-791.
49. Yin, K., Zhang, X. and Qiu, Y. (2006) Association between beta2-adrenergic receptor genetic polymorphisms and nocturnal asthmatic patients of Chinese Han nationality, Respiration 73: 464-467.
50. Yin, P., Jiang, C.Q., Cheng, K.K., Lam, T.-H., Lam, K.H., Miller, M.R. et al. (2007) Passive smoking exposure and risk of COPD among adults in China: the Guangzhou Biobank Cohort Study, Lancet 370: 751-757.
51. Zhang, G., Hayden, C.M., Khoo, S.-K., Candelaria, P., Laing, I.A., Turner, S. et al. (2007) ß2-adrenoceptor polymorphisms and asthma phenotypes: interactions with passive smoking, Eur Respir J 30: 48-55.